❤️Conditions & CareFDA Approves First New Class of Schizophrenia Medication in Decades
Federal regulators have approved a novel antipsychotic medication called Cobenfy, marking a significant shift from decades-old dopamine-targeting treatments.
❤️Conditions & CareFederal regulators have approved a novel antipsychotic medication called Cobenfy, marking a significant shift from decades-old dopamine-targeting treatments.
❤️Conditions & CareResearch shows about half of individuals with schizophrenia also experience anxiety symptoms. Experts highlight practical methods, such as cognitive behavioral techniques…
A meta-analysis involving more than 1.6 million participants found that 18.7 percent of individuals with schizophrenia receive long-acting injectable antipsychotics. Pres…
🔬ResearchA recent study published in Neuroscience and Biobehavioral Reviews proposes that energy bottlenecks in brain cells may disrupt neural rhythms and alter the perception of …
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.